Aug 08, 2025 06:45
NBIX - Neurocrine Biosciences Inc
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 140.24 2.93 (2.09%) | -0.1 (-0.07%) | 0.0 (0.0%) | 0.41 (0.29%) | --- | 2.93 (2.09%) | --- | --- |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 1.09
- Diluted EPS:
- 1.06
- Basic P/E:
- 131.3486
- Diluted P/E:
- 135.066
- RSI(14) 1m:
- 66.86
- VWAP:
- 143.23
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Aug 01, 2025 04:15
Jul 16, 2025 11:00
Jun 02, 2025 23:30
May 28, 2025 23:43
May 02, 2025 06:30
Apr 09, 2025 17:00
Mar 06, 2025 18:00
Feb 10, 2025 23:18
Feb 07, 2025 14:08